- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Monday, 27 February 2023
-
Current Status:
Answered by Ben Macpherson on 10 March 2023
To ask the Scottish Government what proportion of Scottish Child Payment applicants have had their payments delayed, and what the total value is of any such delayed payments.
Answer
I refer the member to the answer to the question S6W-15375 on 10 March 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at /chamber-and-committees/written-questions-and-answers .
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Wednesday, 22 February 2023
-
Current Status:
Answered by Humza Yousaf on 8 March 2023
To ask the Scottish Government what steps it is taking to reduce any regional variation in levels of access to advanced therapies for rheumatoid arthritis.
Answer
In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly-licensed medicines. Following receipt of a submission from the manufacturer, the SMC carries out an appraisal of the medicine and then determines whether it should be accepted for routine use within the NHS in Scotland. The SMC appraisal is undertaken independently of Scottish Ministers and is based on the clinical and cost-effectiveness of the medicine at a population level. Following the appraisal process, the SMC publishes advice for NHS Scotland Health Boards to consider. The decision to prescribe a medicine for a patient, and which medicine to prescribe, is entirely for the clinician in charge of a patient’s care, having taken into account the patient’s clinical condition and any relevant clinical guidance.
To support financial and service planning, the SMC also provides Health Boards – in confidence – information on medicines that may require a companion diagnostic through regular Forward Look reports which include emerging new medicines, including advanced therapy medicinal products (ATMPs).
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Tuesday, 28 February 2023
-
Current Status:
Answered by Christina McKelvie on 8 March 2023
To ask the Scottish Government how much it has allocated to a National Transition to Adulthood Strategy in the Scottish Budget 2023-24.
Answer
To date, we have been laying the foundations to deliver on Scotland’s first National Transitions to Adulthood Strategy to support disabled young people as they make the transition to young adult life, through research and engagement.
The scope, vision, aims and national priorities for the strategy will now be developed through external stakeholder engagement and wider consultation. Staffing costs for this work will be met from our operating costs budget for 2023-24.
The costs associated with the implementation of the Strategy will be determined by the actions that are developed and ultimately included, once agreed.
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Wednesday, 22 February 2023
-
Current Status:
Answered by Humza Yousaf on 8 March 2023
To ask the Scottish Government what assessment it has made of the impact of the COVID-19 pandemic on rheumatology services.
Answer
The global pandemic was the biggest shock our NHS has faced in its 74 year existence. Our NHS Recovery Plan published on 25 August 2021 invests £1 billion of targeted funding over five years to increase NHS capacity, deliver reform, and ensure everyone has the treatment they need at the right time, in the right place, and as quickly as possible.
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Wednesday, 22 February 2023
-
Current Status:
Answered by Humza Yousaf on 8 March 2023
To ask the Scottish Government how it is supporting access to advanced therapies for people with rheumatoid arthritis.
Answer
The Scottish Government is committed to ensuring that people living in Scotland with long term conditions such as rheumatoid arthritis are able to access the best possible care and support.
The Scottish Government is working to ensure an overarching approach for advanced therapy medicinal products (ATMPs) is in place in order to facilitate a ‘once for Scotland’ approach, where possible. We recognise that there are wide-ranging implications and challenges for the managed introduction of these personalised medicines, and are committed to adopting a co-ordinated approach where practical. We are working across Government to develop our understanding of the future direction for this area of medicines policy, including associated genomic testing and service planning implications for the NHS.
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Wednesday, 22 February 2023
-
Current Status:
Answered by Humza Yousaf on 8 March 2023
To ask the Scottish Government whether it will provide the current average (a) remission rate and (b) waiting time for treatment for rheumatoid arthritis, broken down by NHS board.
Answer
The information requested is not held centrally and is a matter for NHS Boards locally.
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Wednesday, 22 February 2023
-
Current Status:
Answered by Humza Yousaf on 8 March 2023
To ask the Scottish Government whether it will provide an update on how it plans to improve disease control rates for (a) rheumatoid arthritis, (b) axial spondyloarthritis and (c) psoriatic arthritis.
Answer
The Scottish Government expects health care professionals to deliver high quality person-centred care in line with best practice guidance. The NICE (National Institute for Health and Care Excellence) guideline on management of rheumatoid arthritis in adults (NG100) is available on its website: www.nice.org.uk. The Scottish Intercollegiate Guidelines Network (SIGN) guideline on management of psoriatic arthritis in adults (SIGN 121) is available on its website: www.sign.ac.uk.
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Wednesday, 22 February 2023
-
Current Status:
Answered by Humza Yousaf on 8 March 2023
To ask the Scottish Government how it is supporting NHS boards to (a) manage patient pathways and (b) track patient outcomes for people living with rheumatic conditions.
Answer
I refer the member to the answer to question S6W-15269 on 8 March 2023. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at Questions and answers | Scottish Parliament Website .
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Thursday, 23 February 2023
-
Current Status:
Answered by Ben Macpherson on 6 March 2023
To ask the Scottish Government, of the households that have claimed social security benefits in the last 12 months, how many had a (a) woman and (b) man as the lead claimant.
Answer
Social Security Scotland does not routinely produce information on households claiming social security benefits.
Information on the characteristics of applicants, including gender, is published as part of Official Statistics publications on Social Security Scotland client diversity and equalities analysis.
These statistics were most recently published in September 2021 and are available at: .
There is currently work being undertaken to produce an update to this publication, which will be published by the end of summer 2023. This will cover the period from June 2021 to October 2022.
- Asked by: Pam Duncan-Glancy, MSP for Glasgow, Scottish Labour
-
Date lodged: Tuesday, 21 February 2023
-
Current Status:
Answered by Ben Macpherson on 6 March 2023
To ask the Scottish Government, of the couples who are claiming social security benefits in Scotland, how many have a (a) woman and (b) man as the lead claimant.
Answer
Social Security Scotland does not routinely produce information on couples claiming social security benefits.
Information on the characteristics of applicants, including gender, is published as part of Official Statistics publications on Social Security Scotland client diversity and equalities analysis.
These statistics were most recently published in September 2021 and are available at:
There is currently work being undertaken to produce an update to this publication, which will be published by the end of summer 2023. This will cover the period from June 2021 to October 2022.